banner
Autophagy inhibitor, EAD1, Purity ≥98%
Inquiry

Cat. No.: X24-09-YM694

Autophagy inhibitor, EAD1, Purity ≥98%

Synonym: 1644388-26-0; EAD 1; EAD-1; N-[[1-[(4-Chlorophenyl)methyl]triazol-4-yl]methyl]-N'-[2-[(7-chloroquinolin-4-yl)amino]ethyl]-N'-methylethane-1,2-diamine; Autophagy inhibitor

  • CAS Number: 1644388-26-0
  • Compound CID: 118735232
img
Product Size
1 mg; 5 mg; 10 mg; 20 mg
Price
Datasheet
MSDS
Properties
Description
EAD1 is an effective autophagy signaling inhibitor, that has the ability to prevent the pathway of autophagy. The molecular weight of the compound is 484.42, and its molecular formula is C24H27Cl2N7.
Molecular Weight
484.42
Molecular Formula
C24H27Cl2N7
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
EAD1 can be studied extensively for its potential therapeutic applications in the treatment of tumors with mTOR pathway dysregulation, and could play a role in aging-related studies.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0